Navigation Links
Transfection Technologies Market is Growing at an Estimated CAGR of 9.32% & to Reach $601 Million by 2017- MarketsandMarkets
Date:1/20/2013

or in the transfection technology market. The market is segmented based on the technologies, where Bio-chemical based methods hold the major share in the market because of its cost advantage and simplicity over other technologies. Physical based methods are growing at a healthy pace because of its ability to transfect hard to transfect cells, while the viral mediated methods are growing at a steady phase.

The key growth area of transfection products is the application in therapeutic area, where transfection is effectively used in treatment of cancer and other genetic disorders. Growth in gene therapy is also driving the transfection market. Gene therapy promises to cure various diseases and disorders, and is one of the growing application in therapeutic segments with four approved drugs being in market. Electrochemotherapy is another upcoming therapeutic method being tested widely in Europe and America for treating cutaneous and sub-cutaneous tumors.

The global market for transfection products was estimated to be worth US $385 million in 2012 and is expected to reach US $601 million by 2017, growing at a CAGR of 9.32% from 2012 to 2017.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electro
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. When Can You Get Pregnant? Many Women Don’t Know, But a Simple Family Planning Method Now Available from Cycle Technologies Can Help
2. Life Support Technologies Group Appoints Edward Golembe, MD as Co-Clinical Director
3. Life Support Technologies Group Appoints Scott Gorenstein, MD as Co-Clinical Director
4. National Academy of Inventors inaugural conference highlights innovative technologies
5. Application Development Firm Anahata Technologies Pty Ltd Announces GlassFish as Application Server of Choice
6. Application Development Company Anahata Technologies Announces CentOS As Server OS Of Choice For Enterprise Applications
7. Anahata Technologies Pty Ltd Announces Software Development Partnership with MYOB
8. The Life Support Technologies Group Announces 2013 Hyperbaric Medical Training Course Dates
9. Anahata Technologies to Offer Custom Software Solution Development Services for Small and Medium Businesses in 2013
10. Application Development Services Provider Anahata Technologies Reviews 2012 Exercise, Sets 100% Customer Satisfaction Goal for 2013
11. Application Development Firm Anahata Technologies Pty Ltd Announces JavaFX 2.0 as Technology of Choice for Enterprise Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... is available in German . ... intracellular signaling molecules, but their mode of action is ... cellular function and behavior, while at high concentrations they ... DNA. To analyze how redox signaling unfolds in single ... technique has been developed jointly by the teams of ...
(Date:4/22/2014)... Nearly 7 in 10 Americans support mandated coverage of ... by researchers at the University of Michigan Health System. ... age of 18 at home, and adults with private ... adults to support universal coverage of birth control medications, ... Journal of the American Medical Association ( JAMA ...
(Date:4/22/2014)... (trade name: NovoEight) has been approved since November 2013 ... with haemophilia A. In an early benefit assessment pursuant ... for Medicinal Products" (AMNOG), the German Institute for Quality ... new active ingredient offers an added benefit over the ... an added benefit of turoctocog alfa is not proven. ...
(Date:4/22/2014)... 22, 2014) Cedars-Sinai stroke intervention researchers have been ... Stroke, part of the National Institutes of Health, will ... Phase II clinical trial of an experimental drug for ... in combination with recombinant tissue plasminogen activator, or rtPA ... strokes shortly after onset. In laboratory rodent studies, 3K3A-APC, ...
(Date:4/22/2014)... have found that the anxiety experienced with a ... impact a woman,s overall well-being. Their findings are ... was published online in the April 21, 2014 ... 40 to 60 percent of women who undergo ... experience a false-positive mammogram. Such mammograms require additional ...
Breaking Medicine News(10 mins):Health News:Neuroimaging: Live from inside the cell 2Health News:More than two-thirds of Americans support mandated coverage of birth control in health plans 2Health News:Turoctocog alfa in patients with hemophilia A: Added benefit not proven 2Health News:Turoctocog alfa in patients with hemophilia A: Added benefit not proven 3Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 3Health News:False-positive mammogram anxiety has limited impact on women's well-being 2
... Depression Management Program Employs Telephone Contact in TreatmentCOLUMBIA, S.C., ... (CBA) was awarded Silver Honors for Health ... organization, URAC . The honor was ... Health Care Consumer Empowerment and Protection Awards Gala ...
... to Draw Attention to Connecticut,s Growing Burden of Chronic Disease ... Loss Caused by CrisisHARTFORD, Conn., April 6 National and ... joining to launch a Partnership to call for comprehensive health ... disease here in Connecticut and across the nation. , ...
... study identify a biomarker that may be useful for predicting ... in young children. The research, published by Cell Press in ... , also provides new information about the molecular signals that ... cancer. , Retinoic acid (RA) is a metabolite of Vitamin ...
... nation to receive accreditationGREEN BAY, Wis., ... one of the first four hospitals in the ... Program for Breast Centers (NAPBC), administered by the ... program in Wisconsin to earn this recognition.(Logo: ...
... the level of patient care and streamline workflow for more efficient ... from the 2009 Annual HIMSS Conference & Exhibition at McCormick Place ... , ... Chicago, IL (PRWEB) April 6, 2009 -- ...
... A ,Biggest Loser, Finalist from the Lehigh ... Pa., April 6 Department of Health Secretary Everette James ... lunchtime fitness walk around the Capitol complex to bring awareness ... their own health. "As the state agency with ...
Cached Medicine News:Health News:Companion Benefit Alternatives Awarded Silver Honors for Best Practices in Health Plans and Health Networks by URAC 2Health News:Companion Benefit Alternatives Awarded Silver Honors for Best Practices in Health Plans and Health Networks by URAC 3Health News:Bipartisan CT Coalition Forms to Fight Spiraling Health Care Costs 2Health News:Biomarker associated with poor outcome in aggressive childhood cancer 2Health News:Aurora BayCare is Wisconsin's First Nationally Accredited Breast Program 2Health News:Orion Health Concerto Whiteboard Helps Emergency Rooms and Wards Track Patient Status 2Health News:Orion Health Concerto Whiteboard Helps Emergency Rooms and Wards Track Patient Status 3Health News:Secretary of Health 'Walks the Walk' to Kick Off National Public Health Week 2
(Date:1/15/2014)... Mass. , Jan. 15, 2014  Zafgen, Inc., ... unmet needs of severely obese patients, today announced ... beloranib, a selective inhibitor of methionine aminopeptidase 2 ... severe form of genetic obesity.  These results showed ...
(Date:1/14/2014)... The Brandeis Medical Center, led by Dr. Emmanuel Brandeis , ... laser tattoo removal experience with the advanced Astanza Duality laser and ... quality cosmetic services with cutting edge medical technology and offering expert ... has seen a dramatic increase in the presence of ...
(Date:1/14/2014)... CLEVELAND , Jan. 14, 2014 NineSigma ... will hold its Innovation Leadership Summit , May ... in Cleveland Ohio . ... innovators and organizations committed to breakthrough achievements through open ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
The Trans-Blot transfer cell, used with the included PowerPac 200 power supply, performs efficient, high-intensity electrophoretic transfers. The Trans-Blot cell offers many advantages....
... specifically designed to work with the EC120 ... a small tank blotter that incorporates the ... buffer requirements and fast transfer rates), with ... blotting such as arcing and buffer depletion. ...
... Semi-Dry Blotting System. 20cm x ... Southern gels reliably and quickly. The ... are durable and corrosion free. These ... excellent transfers. Also available in 35cm ...
... SD semi-dry transfer cell allows ... Using a platinum-coated titanium plate ... stainless steel plate as the ... transfers in a horizontal configuration ...
Medicine Products: